Corvex Misses by $0.51 per Share as Revenue Hits $4.98 Million

Corvex (NASDAQ:MOVE) reported a quarterly loss of $0.60 per share on Thursday, missing analysts' consensus estimate of a $0.09 loss by $0.51 per share. Revenue came in at $4.98 million for the quarter against analyst expectations of $5.54 million, according to FiscalAI.

The market reacted quickly. Shares traded down $0.51 in mid-day trading Thursday to $5.19, on volume of 84,049 shares — well below the stock's average of 524,070. The company now carries a market capitalization of $163.84 million.

What did the quarter actually deliver?

The headline loss masks sequential progress. Quarterly revenue rose to $5 million from $3.8 million in the prior quarter. Contracted ARR (annual recurring revenue, a forward-looking measure of committed annual income) on live compute stood at $21.6 million at quarter-end and ticked up to $21.7 million as of the earnings call.

Still, Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) remained negative at $3.2 million. Management also flagged a caution for anyone modeling off the ARR figure: live ARR is a point-in-time metric, not a revenue forecast.

The takeaway: revenue is accelerating, but the company remains cash-flow negative by a meaningful margin.

How much capacity is under contract?

All 7.7 megawatts of planned critical IT capacity is under contract. Of that, 1.5 MW is already live, and the remaining 6.2 MW is on track to be ready for service in the fourth quarter.

Corvex is also in final discussions with an AI-native customer for more than 1,000 Blackwell GPUs at its Mid-Atlantic 1 site — though the offtake agreements (long-term purchase contracts for the compute capacity) have not yet been completed.

The takeaway: the pipeline is fully contracted on paper, but two big revenue catalysts — the 6.2 MW buildout and the GPU deal — still need to close and come online.

What is Token Factory?

On September 30, Corvex launched Token Factory, a product offering pay-per-token inference (charging customers only for the AI computations they actually run) using open-weight models with zero data retention by default. Management sees potential for higher revenue per GPU hour when demand is sufficient.

Don't expect it to move the numbers soon. The product is in its early weeks, and the company expects a meaningful revenue contribution to begin in 2027.

The takeaway: Token Factory is an option on future demand, not a 2025 or 2026 revenue driver.

Where does the balance sheet stand?

Corvex ended the quarter with $42 million in cash, helped by a September private placement. The company said it has not used its new at-the-market facility (a program allowing gradual share sales into the open market).

Dilution is still creeping up. Shares outstanding on an as-converted basis rose to roughly 60.9 million from 56.6 million in July. Management said it aims to prioritize customer prepayments and project-level debt before turning to equity financing.

The takeaway: cash covers the near term, and the stated funding hierarchy puts equity last.

What about the internal controls weakness?

The material weakness in internal controls remains unremediated. Corvex is designing and documenting controls and expects to begin testing them in the first half of 2027. Management said full remediation will take longer, until the controls have operated for a sufficient period and been tested.

The takeaway: an accounting-grade red flag stays on the books for at least another year and a half.

What are analysts saying?

The research desk is split three ways:

• Zacks Research upgraded Corvex to a "hold" rating on Friday, September 18.
• Weiss Ratings downgraded the stock from "sell (d)" to "sell (e)" on Thursday, October 8.
• Chardan Capital set an $18.75 target price with a "buy" rating on Wednesday, September 16.

Across coverage, one analyst rates the stock Buy, one Hold and one Sell. Per MarketBeat.com, the consensus rating is "Hold" with an average target price of $18.75.

How weak is the stock technically?

The technical picture reflects the slide. Corvex trades at $5.19, against a 50-day simple moving average of $9.65 and a 200-day simple moving average of $13.79. The stock has a twelve-month range of $4.34 to $26.72.

On ratios: a quick ratio of 1.80, a current ratio of 1.80, a debt-to-equity ratio of 4.28, a P/E ratio of -0.27 and a beta of 0.92.

A $4.34 low sitting just below Thursday's price tells you how close this stock is to its worst level of the past year.